EBS:NYE-Emergent Biosolutions Inc (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 7.49

Change

0.00 (0.00)%

Market Cap

N/A

Volume

3.53M

Analyst Target

USD 112.29
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

N/A

USD 88.29B
HLN Haleon plc

N/A

USD 48.57B
TAK Takeda Pharmaceutical Co Ltd A..

N/A

USD 47.42B
RDY Dr. Reddy’s Laboratories Ltd..

N/A

USD 13.46B
CTLT Catalent Inc

N/A

USD 10.91B
ELAN Elanco Animal Health

N/A

USD 6.96B
BHC Bausch Health Companies Inc

N/A

USD 3.04B
AMRX Amneal Pharmaceuticals, Inc. C..

N/A

USD 2.54B
CPHI China Pharma Holdings Inc

N/A

USD 3.66M
YCBD cbdMD Inc

N/A

USD 1.73M

ETFs Containing EBS

XB4A:F Xtrackers ATX UCITS ETF 1.. 21.50 % 0.00 %

N/A

USD 0.05B
XB4A:XETRA Xtrackers ATX UCITS ETF 1.. 21.50 % 0.00 %

N/A

USD 0.05B
EXXX:XETRA iShares ATX UCITS ETF (DE.. 21.35 % 0.00 %

N/A

USD 0.09B
EBNK:CA Evolve European Banks Enh.. 5.01 % 0.00 %

N/A

CAD 3.39M
IVES Amplify ETF Trust 3.51 % 0.00 %

N/A

USD 0.02B
IS3H:XETRA iShares MSCI EMU Mid Cap .. 1.86 % 0.00 %

N/A

USD 0.13B
EMUM:SW iShares MSCI EMU Mid Cap .. 1.86 % 0.00 %

N/A

USD 0.13B
LDEU:LSE L&G Quality Equity Divide.. 1.39 % 0.00 %

N/A

USD 0.04B
LGGE:XETRA L&G Quality Equity Divide.. 1.38 % 0.00 %

N/A

USD 0.03B
LDEG:LSE L&G Quality Equity Divide.. 1.30 % 0.00 %

N/A

N/A
EL43:XETRA Deka MSCI Europe MC UCITS.. 0.97 % 0.00 %

N/A

USD 0.02B
EUMD:LSE iShares MSCI Europe Mid C.. 0.94 % 0.00 %

N/A

USD 0.26B
IS3H:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 212.08% 87% B+ 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 212.08% 87% B+ 94% A
Trailing 12 Months  
Capital Gain 120.29% 87% B+ 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 120.29% 87% B+ 93% A
Trailing 5 Years  
Capital Gain -85.67% 14% F 3% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -85.67% 14% F 3% F
Average Annual (5 Year Horizon)  
Capital Gain -34.57% N/A N/A 1% F
Dividend Return -34.57% N/A N/A 1% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 55.61% N/A N/A 16% F
Risk Adjusted Return -62.15% N/A N/A 4% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector